Drug Rehablitation for College Students Explained By TheRecover
Apr 09, 2018 05:52 am UTC| Business
SAN DIEGO, April 09, 2018 -- It is very intricate for the parents to keep an eye on their children all the time. Thus in some cases children take advantage of this freedom and get indulged in several illegal activities....
TheRecover.com Defines Some of the Common Drug Rehabilitation Processes
Apr 09, 2018 05:51 am UTC| Business
SAN DIEGO, April 09, 2018 -- TheRecover.com defines three of the most common drug rehabilitation processes. ...
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
Apr 09, 2018 05:16 am UTC| Business
Basel, Switzerland, April 09, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Avir Pharma Inc. ("Avir Pharma") has launched Basilea's hospital antibiotic Zevtera® (ceftobiprole) in Canada. ...
TheRecover.com, Signs of Heroin Addiction and What to Look For
Apr 09, 2018 05:02 am UTC| Business
SAN DIEGO, April 09, 2018 -- If a loved one is addicted to heroin, then discovering the truth can sometimes be more difficult than you would think. Addicts aren’t typically proud of their drug use and do everything they...
argenx appoints Keith Woods as Chief Operating Officer
Apr 09, 2018 05:01 am UTC| Business
April 9, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment...
General Data Protection Regulation (GDPR) Compliance in a Kit
Apr 09, 2018 04:57 am UTC| Business
SAN JOSE, Calif., April 09, 2018 -- SPYRUS, Inc. today announced the availability of two Spring Promotion Trial Kits which will enable IT departments to meet compliance with the new audit and reporting requirements...
AveXis Enters Agreement to be Acquired by Novartis AG for $8.7 billion
Apr 09, 2018 04:45 am UTC| Business
Novartis to acquire AveXis for $218 per share in cash AveXis’ lead product candidate, AVXS-101, expected to enhance Novartis’s position as a gene therapy and neuroscience leader Transaction expected to be completed in...